Compounds, compositions and methods
US9643925B2 · kind B2 · utility
24Cited by
41References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 2015 |
| Grant date | May 9, 2017 |
| Priority date | — |
| Expiry date | Aug 27, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.